Globans Pharma offers information and supply of the medicine to the qualifying patients suffering from non-small cell lung cancer (NSCLC). Erlotinib Tablet Uses In NSCLC Treatment primarily include use as a targeted treatment for some specific mutations in NSCLC patients, whereby the drug acts as an inhibitor for EGFR signaling that promotes the proliferation of cancer cells.